5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Development of 3D PVA scaffolds for cardiac tissue engineering and cell screening applications†

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The aim of this study was the design of a 3D scaffold composed of poly(vinyl) alcohol (PVA) for cardiac tissue engineering (CTE) applications. The PVA scaffold was fabricated using a combination of gas foaming and freeze-drying processes that did not need any cross-linking agents. We obtained a biocompatible porous matrix with excellent mechanical properties. We measured the stress–strain curves of the PVA scaffolds and we showed that the elastic behavior is similar to that of the extracellular matrix of muscles. The SEM observations revealed that the scaffolds possess micro pores having diameters ranging from 10 μm to 370 μm that fit to the dimensions of the cells. A further purpose of this study was to test scaffolds ability to support human induced pluripotent stem cells growth and differentiation into cardiomyocytes. As the proliferation tests show, the number of live stem cells on the scaffold after 12 days was increased with respect to the initial number of cells, revealing the cytocompatibility of the substrate. In addition, the differentiated cells on the PVA scaffolds expressed anti-troponin T, a marker specific of the cardiac sarcomere. We demonstrated the ability of the cardiomyocytes to pulse within the scaffolds. In conclusion, the developed scaffold show the potential to be used as a biomaterial for CTE applications.

          Abstract

          The aim of this study was the design of a 3D scaffold composed of poly(vinyl) alcohol (PVA) for cardiac tissue engineering (CTE) applications.

          Related collections

          Most cited references40

          • Record: found
          • Abstract: found
          • Article: not found

          Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

          Differentiated cells can be reprogrammed to an embryonic-like state by transfer of nuclear contents into oocytes or by fusion with embryonic stem (ES) cells. Little is known about factors that induce this reprogramming. Here, we demonstrate induction of pluripotent stem cells from mouse embryonic or adult fibroblasts by introducing four factors, Oct3/4, Sox2, c-Myc, and Klf4, under ES cell culture conditions. Unexpectedly, Nanog was dispensable. These cells, which we designated iPS (induced pluripotent stem) cells, exhibit the morphology and growth properties of ES cells and express ES cell marker genes. Subcutaneous transplantation of iPS cells into nude mice resulted in tumors containing a variety of tissues from all three germ layers. Following injection into blastocysts, iPS cells contributed to mouse embryonic development. These data demonstrate that pluripotent stem cells can be directly generated from fibroblast cultures by the addition of only a few defined factors.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Biomaterials & scaffolds for tissue engineering

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Evidence for cardiomyocyte renewal in humans.

              It has been difficult to establish whether we are limited to the heart muscle cells we are born with or if cardiomyocytes are generated also later in life. We have taken advantage of the integration of carbon-14, generated by nuclear bomb tests during the Cold War, into DNA to establish the age of cardiomyocytes in humans. We report that cardiomyocytes renew, with a gradual decrease from 1% turning over annually at the age of 25 to 0.45% at the age of 75. Fewer than 50% of cardiomyocytes are exchanged during a normal life span. The capacity to generate cardiomyocytes in the adult human heart suggests that it may be rational to work toward the development of therapeutic strategies aimed at stimulating this process in cardiac pathologies.
                Bookmark

                Author and article information

                Journal
                RSC Adv
                RSC Adv
                RA
                RSCACL
                RSC Advances
                The Royal Society of Chemistry
                2046-2069
                14 February 2019
                30 January 2019
                14 February 2019
                : 9
                : 8
                : 4246-4257
                Affiliations
                [a] Department of Health Sciences, University of Magna Graecia 88100 Catanzaro Italy elisabettadattola@ 123456gmail.com +39-3202851897
                [b] Research Center for Advanced Biochemistry and Molecular Biology, Stem Cell Laboratory, Department of Experimental and Clinical Medicine, University “Magna Graecia” of Catanzaro 88100 Loc. Germaneto Catanzaro Italy
                [c] BioNEM (Bio and Nano Engineering and Technology for Medicine) Laboratory, Department of Experimental and Clinical Medicine, University of Magna Graecia 88100 Catanzaro Italy
                [d] SMILEs Lab, Physical Science and Engineering (PSE), Biological and Environmental Science and Engineering (BESE) Divisions, King Abdullah University of Science and Technology Thuwal 23955-6900 Kingdom of Saudi Arabia
                [e] DIMEG (Department of Mechanical, Energy and Management Engineering), University of Calabria 87036 Rende CS Italy
                Author information
                https://orcid.org/0000-0003-2116-7865
                https://orcid.org/0000-0002-9204-5358
                https://orcid.org/0000-0001-9284-7492
                https://orcid.org/0000-0001-5886-4678
                https://orcid.org/0000-0001-6313-1866
                Article
                c8ra08187e
                10.1039/c8ra08187e
                9060459
                35520194
                4eb9969b-2444-4b7e-ae12-ecda49d88743
                This journal is © The Royal Society of Chemistry
                History
                : 3 October 2018
                : 5 January 2019
                Page count
                Pages: 12
                Funding
                Funded by: Ministero della Salute, doi 10.13039/501100003196;
                Award ID: GR-2010-2311677
                Award ID: CUP J65C13001350001
                Categories
                Chemistry
                Custom metadata
                Paginated Article

                Comments

                Comment on this article